We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

153 hedge funds and large institutions have $326M invested in Filana Therapeutics in 2023 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 45 increasing their positions, 39 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 16

51% more capital invested

Capital invested by funds: $215M → $326M (+$110M)

44% more call options, than puts

Call options by funds: $81.5M | Put options by funds: $56.7M

15% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 39

9% more funds holding

Funds holding: 140 → 153 (+13)

3.49% more ownership

Funds ownership: 30.83% → 34.32% (+3.5%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

Holders
153
Holders Change
+13
Holders Change %
+9.29%
% of All Funds
2.23%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
31
Increased
45
Reduced
39
Closed
16
Calls
$81.5M
Puts
$56.7M
Net Calls
+$24.8M
Net Calls Change
+$18.3M

Top Buyers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
+$13.7M
2
CAC
Cowen and Company
New York
+$10.6M
3
Jane Street
Jane Street
New York
+$7.62M
4
BlackRock
BlackRock
New York
+$4.19M
5
National Bank of Canada
National Bank of Canada
Quebec, Canada
+$3.13M

Top Sellers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
-$8.19M
2
SG Americas Securities
SG Americas Securities
New York
-$3.89M
3
SC
Sculptor Capital
New York
-$3.69M
4
JFG
Jefferies Financial Group
New York
-$2.95M
5
CF
Cantor Fitzgerald
New York
-$2.84M
Name Holding Trade Value Shares
Change 		Change in
Stake
Northwestern Mutual Wealth Management
126
Northwestern Mutual Wealth Management
Wisconsin
$4.84K +$4.54K +215 New
Qube Research & Technologies (QRT)
127
Qube Research & Technologies (QRT)
United Kingdom
$4.62K +$4.33K +205 New
Comerica Bank
128
Comerica Bank
Texas
$4.5K – – –
PP
129
PFS Partners
New Jersey
$4.5K – – –
EC
130
EntryPoint Capital
New York
$3.83K +$3.59K +170 New
SAG
131
Spotlight Asset Group
Illinois
$3.49K – – –
CFD
132
Creative Financial Designs
Indiana
$3.15K – – –
SPIA
133
Steward Partners Investment Advisory
New York
$2.81K +$1.06K +50 +67%
LC
134
Lindbrook Capital
California
$2.59K -$338 -16 -12%
LFG
135
Larson Financial Group
Missouri
$2.25K – – –
QCG
136
Quadrant Capital Group
Ohio
$2.21K +$2.07K +98 New
RMC
137
Resources Management Corp
Connecticut
$2K – – –
SWA
138
SOA Wealth Advisors
New York
$1.76K – – –
WTA
139
Washington Trust Advisors
Massachusetts
$1.69K +$1.58K +75 New
GWM
140
Geneos Wealth Management
Colorado
$1.69K – – –
FCMT
141
Founders Capital Management (Texas)
Texas
$1.58K – – –
HPC
142
HM Payson & Co
Maine
$1.13K – – –
NA
143
NewEdge Advisors
Louisiana
$1.13K – – –
SSB
144
Sandy Spring Bank
Maryland
$1.13K – – –
PS
145
Principal Securities
Iowa
$1.13K +$1.06K +50 New
FFO
146
Fortitude Family Office
Arizona
$1.1K +$1.03K +49 New
CWA
147
Carolina Wealth Advisors
South Carolina
$1.08K – – –
S
148
SignatureFD
Georgia
$968 -$782 -37 -46%
SWM
149
Spire Wealth Management
Virginia
$792 +$634 +30 New
EWA
150
EverSource Wealth Advisors
Alabama
$113 – – –
3 4 5
6
7

FLNA Hedge Fund Activity: Q4 2023 in Review

153 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q4 2023, worth a combined $326M — up 51% from $215M a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new FLNA positions and 16 closed out — a net gain of 15 holders — while 45 added to existing stakes and 39 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $13.7M. The largest seller was Bank of America, cutting an estimated $8.19M.

  • 153 institutional investors held Filana Therapeutics (FLNA) as of Q4 2023, up from 140 in Q3 2023.
  • Funds reported $326M of Filana Therapeutics stock for Q4 2023, up 51% quarter-over-quarter.
  • 31 funds opened new Filana Therapeutics positions in Q4 2023 and 16 closed out, a net change of +15 holders.
  • The largest Filana Therapeutics buyer in Q4 2023 was Morgan Stanley, an estimated $13.7M added.
  • The largest Filana Therapeutics seller in Q4 2023 was Bank of America, an estimated $8.19M sold.

Based on aggregated 13F filings for Q4 2023.